These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7516362)

  • 1. Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
    Tassopoulos NC; Hatzakis AE; Papatheodoridis GV; Karvountzis G; Troonen H; Lennartz L
    J Hepatol; 1994 Feb; 20(2):305-6. PubMed ID: 7516362
    [No Abstract]   [Full Text] [Related]  

  • 2. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
    Nagayama R; Miyake K; Tsuda F; Okamoto H
    J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal core-IgM antibodies to hepatitis C virus are not predictive of successful alpha-interferon therapy.
    Caporaso N; Tuccillo C; Morisco F
    J Hepatol; 1995 Mar; 22(3):377. PubMed ID: 7608491
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
    Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V
    J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha.
    Löhr H; Nagel C; Dienes HP; Simpson B; Michel G; Goergen B; Meyer zum Büschenfelde KH; Gerken G
    Hepatology; 1994 Dec; 20(6):1383-9. PubMed ID: 7526999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are basal core-IgM antibodies to hepatitis C virus predictive of successful alpha-interferon therapy?
    Pawlotsky JM; Roudot-Thoraval F; Bastie A; Duval J; Dhumeaux D
    J Hepatol; 1995 Dec; 23(6):760-1. PubMed ID: 8750179
    [No Abstract]   [Full Text] [Related]  

  • 8. IgM antibodies to hepatitis C virus and haemodialysis patients.
    Navarro JF; Teruel J; Mateos M; Ortuño J
    Nephrol Dial Transplant; 1994; 9(8):1211. PubMed ID: 7528362
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing chronic hepatitis C virus infection.
    Lau JY; Davis GL
    BMJ; 1993 Feb; 306(6876):469-70. PubMed ID: 7680588
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation.
    Boillot O; Berger F; Rasolofo E; Mion F; Chevallier P; Gille D; Paliard P
    Transplant Proc; 1995 Aug; 27(4):2501. PubMed ID: 7544508
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C.
    Brillanti S; Masci C; Ricci P; Miglioli M; Barbara L
    Hepatology; 1992 Jun; 15(6):998-1001. PubMed ID: 1317344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV core IgM and IgG antibodies in blood donors.
    Kapprell HP; Majnak A; Medgyesi GA; Szabó JE; Michel G; Albrecht M; Heyermann H; Hampl H; Troonen H
    Vox Sang; 1995; 68(1):57-8. PubMed ID: 7536991
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T; Onji M; Michitaka K; Ohta Y
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
    Yuki N; Hayashi N; Ohkawa K; Hagiwara H; Oshita M; Katayama K; Sasaki Y; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.
    Genesca J; Esteban JI; Quer J; Viladomiu LL; Gonzalez A; Esteban R; Guardia J
    Gut; 1993; 34(2 Suppl):S62-3. PubMed ID: 7686120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy.
    Orito E; Mizokami M; Mizoguchi N; Ohba K; Tohnai M; Yamanaka H; Oguri T; Hirashima N; Koide T; Kano H
    J Hepatol; 1994 Jul; 21(1):130-2. PubMed ID: 7525694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C: diagnosis and treatment.
    Scotiniotis I; Brass CA; Malet PF
    J Gen Intern Med; 1995 May; 10(5):273-82. PubMed ID: 7542329
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.